Dravet syndrome is a rare and severe form of epilepsy that typically manifests in infancy and is characterized by prolonged, ...

Discover top biotech associations that drive industry growth through collaboration, networking, and strategic partnerships ...

RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.

Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.

On a mission to overcome the dosing challenges posed by radiotherapy, French nanotherapy company Nanobiotix is developing a ...

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...